ARCHIVES

Raloxifene Protects Women At High or Low Risk of Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

CVS To Stop Tobacco Sales at Pharmacies

February 7, 2014

NCI-Approved Clinical Trials

October 27, 2006

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

Higher Response For Gleevec In Trial; CML Patients Allowed To Switch

January 25, 2002

ACC Will Develop Standards, Patient Management Guidelines To Upgrade Community Cancer Programs

March 23, 1984

Columbus CCP Forms New Entity to Administer CCOP

July 20, 1990